Crosstalk Among Mitophagy, Pyroptosis, Ferroptosis, and Necroptosis in Central Nervous System Injuries
Overview
Authors
Affiliations
Central nervous system injuries have a high rate of resulting in disability and mortality; however, at present, effective treatments are lacking. Programmed cell death, which is a genetically determined form of active and ordered cell death with many types, has recently attracted increasing attention due to its functions in determining the fate of cell survival. A growing number of studies have suggested that programmed cell death is involved in central nervous system injuries and plays an important role in the progression of brain damage. In this review, we provide an overview of the role of programmed cell death in central nervous system injuries, including the pathways involved in mitophagy, pyroptosis, ferroptosis, and necroptosis, and the underlying mechanisms by which mitophagy regulates pyroptosis, ferroptosis, and necroptosis. We also discuss the new direction of therapeutic strategies targeting mitophagy for the treatment of central nervous system injuries, with the aim to determine the connection between programmed cell death and central nervous system injuries and to identify new therapies to modulate programmed cell death following central nervous system injury. In conclusion, based on these properties and effects, interventions targeting programmed cell death could be developed as potential therapeutic agents for central nervous system injury patients.
Ma Y, Wang J, Tang C, Liu J, Wu X, Dong X Brain Behav. 2025; 15(3):e70424.
PMID: 40079614 PMC: 11905090. DOI: 10.1002/brb3.70424.
Important regulatory role of mitophagy in diabetic microvascular complications.
Hu X, Lv J, Zhao Y, Li X, Qi W, Wang X J Transl Med. 2025; 23(1):269.
PMID: 40038741 PMC: 11877814. DOI: 10.1186/s12967-025-06307-7.
Insights on the crosstalk among different cell death mechanisms.
Eskander G, Abdelhamid S, Wahdan S, Radwan S Cell Death Discov. 2025; 11(1):56.
PMID: 39929794 PMC: 11811070. DOI: 10.1038/s41420-025-02328-9.
Qiu Y, Cheng L, Xiong Y, Liu Z, Shen C, Wang L CNS Neurosci Ther. 2025; 31(2):e70224.
PMID: 39915907 PMC: 11802338. DOI: 10.1111/cns.70224.
Li X, Luo L, Duan P, Bi Y, Meng Y, Zhang X Inflammation. 2024; .
PMID: 39472380 DOI: 10.1007/s10753-024-02171-7.